Exosomes derived from human mesenchymal stem cells (MSCs) engineered to express the suicide gene yeast cytosine deaminase::uracil phosphoribosyl transferase (yCD::UPRT) represent a new therapeutic approach for tumor-targeted innovative therapy. The yCD::UPRT-MSC-exosomes carry mRNA of the suicide gene in their cargo. Upon internalization by tumor cells, the exosomes inhibit the growth of broad types of cancer cells in vitro, in the presence of a prodrug. Here we describe the method leading to the production and testing of these therapeutic exosomes. The described steps include the preparation of replication-deficient retrovirus possessing the yCD::UPRT suicide gene, and the preparation and selection of MSCs transduced with yCD::UPRT suicide gene. We present procedures to obtain exosomes possessing the ability to induce the death of tumor cells. In addition, we highlight methods for the evaluation of the suicide gene activity of yCD::UPRT-MSC-exosomes.
Mesenchymal stem cells Retrovirus vectors Suicide gene Therapeutic stem cells Conditional medium Exosomes Cancer cells Tumor cell growth inhibition
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
Our studies have been continuously supported by grants awarded to CA from the Slovak League against Cancer.
Shi Y, Du L, Lin L et al (2017) Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov 16:35–52CrossRefGoogle Scholar
Dvorak HF (1986) Tumors: wound that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650–1659CrossRefGoogle Scholar
Kucerova L, Altanerova V, Matuskova M et al (2007) Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 67:6304–6313CrossRefGoogle Scholar
Cihova M, Altanerova V, Altaner C (2011) Stem cell based cancer gene therapy. Mol Pharm 8:1480–1487CrossRefGoogle Scholar
Matuskova M, Hlubinova K, Pastorakova A et al (2010) HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. Cancer Lett 290:58–67CrossRefGoogle Scholar
Kucerova L, Matuskova M, Pastorakova A et al (2008) Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med 10:1071–1082CrossRefGoogle Scholar
Cavarretta IT, Altanerova V, Matuskova M et al (2010) Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol Ther 18:223–231CrossRefGoogle Scholar
Abrate A, Buono R, Canu T et al (2014) Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression. Eur J Cancer 50:2478–2488CrossRefGoogle Scholar
Altanerova V, Cihova M, Babic M et al (2012) Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosine deaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma. Int J Cancer 130:2455–2463CrossRefGoogle Scholar
Altaner C, Altanerova V, Cihova M et al (2014) Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario. Int J Cancer 134:1458–1465CrossRefGoogle Scholar
Altaner C (2013) Stem cell-mediated prodrug gene therapy of high-grade brain tumors. In: Shah K (ed) Stem cell therapeutics for cancer. Wiley-Blackwell, HobokenGoogle Scholar
Leibacher J, Henschler R (2016) Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Res Ther 7:7CrossRefGoogle Scholar
Altaner C (2015) Prodrug gene therapy for cancer mediated by mesenchymal stem/stromal cells engineered to express yeast cytosine deaminase::uracil phosphoribosyltransferase. J Stem Cell Res Ther 5:2157–2633Google Scholar
Altanerova U, Benejova K, Altanerova V et al (2016) Dental pulp mesenchymal stem/stromal cells labeled with iron sucrose release exosomes and cells applied intra-nasally migrate to intracerebral glioblastoma. Neoplasma 63:925–933CrossRefGoogle Scholar
Altanerova U, Jakubechova J, Benejova K et al (2018) Prodrug suicide gene therapy mediated by mesenchymal stem cells exosomes: a new paradigm for cell-free cancer targeted therapy. Int J Cancer. 2018 Aug 11. doi: https://doi.org/10.1002/ijc.31792. [Epub ahead of print] PMID: 30098225
Balyasnikova IV, Ferguson SD, Sengupta S et al (2010) Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma. PLoS One 5:e9750CrossRefGoogle Scholar
Altanerova U, Babincova M, Babinec P et al (2017) Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia. Int J Nanomedicine 12:7923–7936CrossRefGoogle Scholar
Altanerova U, Jakubechova J, Repiska V et al (2017) Exosomes of human mesenchymal stem/stromal/medicinal signaling cells. Minireview. Neoplasma 64:809–815CrossRefGoogle Scholar